Apremilast Impurity 62, identified by its CAS number 1715011-38-3, is a chemical compound associated with the pharmaceutical drug apremilast, which is primarily used in the treatment of autoimmune conditions such as psoriasis and psoriatic arthritis. As an impurity, it may arise during the synthesis or formulation of apremilast and is typically characterized by its molecular structure, which can include specific functional groups that influence its chemical behavior and stability. Impurities like this can affect the efficacy and safety of the final pharmaceutical product, making their identification and quantification crucial in drug development and quality control processes. The characteristics of Apremilast Impurity 62 would include its solubility, stability under various conditions, and potential reactivity with other compounds. Analytical techniques such as HPLC, NMR, and mass spectrometry are often employed to characterize such impurities, ensuring that they are within acceptable limits to maintain the integrity of the primary drug substance.

Apremilast Impurity 62

1715011-38-3: Apremilast Impurity 62, identified by its CAS number 1715011-38-3, is a chemical compound associated with the pharmaceutical drug apremilast, which is primarily used in the treatment of autoimmune conditions such as psoriasis and psoriatic arthritis. As an impurity, it may arise during the synthesis or formulation of apremilast and is typically characterized by its molecular structure, which can include specific functional groups that influence its chemical behavior and stability. Impurities like this can affect the efficacy and safety of the final pharmaceutical product, making their identification and quantification crucial in drug development and quality control processes. The characteristics of Apremilast Impurity 62 would include its solubility, stability under various conditions, and potential reactivity with other compounds. Analytical techniques such as HPLC, NMR, and mass spectrometry are often employed to characterize such impurities, ensuring that they are within acceptable limits to maintain the integrity of the primary drug substance.

CAS 1715011-38-3

Apremilast Impurity 62

(E)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethen-1-amine

Ref: ST-EA-CP-A77095